Page last updated: 2024-10-23

aztreonam and Staphylococcal Skin Infections

aztreonam has been researched along with Staphylococcal Skin Infections in 1 studies

Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.

Staphylococcal Skin Infections: Infections to the skin caused by bacteria of the genus STAPHYLOCOCCUS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tong, A1
Tong, SY1
Zhang, Y1
Lamlertthon, S1
Sharma-Kuinkel, BK1
Rude, T1
Ahn, SH1
Ruffin, F1
Llorens, L1
Tamarana, G1
Biek, D1
Critchley, I1
Fowler, VG1

Other Studies

1 other study available for aztreonam and Staphylococcal Skin Infections

ArticleYear
Panton-Valentine leukocidin is not the primary determinant of outcome for Staphylococcus aureus skin infections: evaluation from the CANVAS studies.
    PloS one, 2012, Volume: 7, Issue:5

    Topics: Age Factors; Aztreonam; Bacterial Toxins; Ceftaroline; Cephalosporins; Electrophoresis, Gel, Pulsed-

2012